EMD Serono Internal US Launch Campaign
Role: Creative Direction
Client: EMD Serono
Instead of the infusions and daily pills already in the MS market, Mavenclad is a short-course oral therapy that breaks treatment down into cycles of 4-5 days for two consecutive months for two years. That pans out to 16-20 treatment days over the two-year course. It’s approved to treat the relapsing-remitting and secondary progressive forms of the disease in adult patients.
To celebrate the release in the US, EMD Serono wanted to evolve the previous European campaign and develop new materials to kick off the launch internally. After conceptualizing and revising we ultimately landed on the key art below. Using the bold dynamic illustrative art we created banners and a building wrap. We also developed a great experiential experience for employees to engage and take selfies to share on social media platforms as well as creating a mural with all their photos that assembled became the key art.
Final Mavenclad art for EMD’s internal campaign.
Key art development. From sketches to finished art.
Building wrap based off the key art illustration.
Internal kickoff campaign with interior building graphics and experiential hashtag mural based.